Startup Insider cover image

Antibiotika-Entwicklung: 4,7 Mio. Pre-Series-A für smartbax – Dr. Robert Macsics

Startup Insider

00:00

smartbax' neuartiger Wirkmechanismus

Robert erklärt ihren Ansatz: Enzym-Stimulation, die Bakterien zur Selbstverdauung bringt, statt Prozesse zu hemmen.

Play episode from 05:26
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app